ArticleAntimicrobial agents and chemotherapy2022

A Novel Oral GyrB/ParE Dual Binding Inhibitor Effective against Multidrug-Resistant

Steven Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.